Less-invasive surfactant administration for neonatal respiratory distress syndrome: a consensus guideline

Less-invasive surfactant administration for neonatal respiratory distress syndrome: a consensus guideline

<p><strong>Introduction:</strong> Less-invasive surfactant administration (LISA) is a method of surfactant delivery to preterm infants for treating respiratory distress syndrome (RDS), which can reduce the composite risk of death or bronchopulmonary dysplasia and the time on mechan...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Reynolds, P, Bustani, P, Darby, C, Fernandez Alvarez, JR, Fox, G, Jones, S, Robertson, SJ, Vasu, V, Roehr, CC
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	Karger Publishers 2021

Παρόμοια τεκμήρια

Addressing the lack of clarity about administering surfactant in preterm infants with respiratory distress
ανά: Ramaswamy, VV, κ.ά.
Έκδοση: (2021)

Addressing the lack of clarity about administering surfactant in preterm infants with respiratory distress syndrome treated with noninvasive respiratory support
ανά: Ramaswamy, VV, κ.ά.
Έκδοση: (2021)

To sedate or not to sedate for less invasive surfactant administration: an ethical approach
ανά: Peterson, J, κ.ά.
Έκδοση: (2021)

Curriculum and assessment tool for less invasive surfactant administration: an international Delphi consensus study
ανά: Breindahl, N, κ.ά.
Έκδοση: (2023)

Guidelines for the use of lung ultrasound to optimise the management of neonatal respiratory distress: international expert consensus
ανά: Jing Liu, κ.ά.
Έκδοση: (2025-02-01)

Efficacy of non‐invasive respiratory support modes for primary respiratory support in preterm neonates with Respiratory Distress Syndrome: Systematic review and network meta‐analysis
ανά: Ramaswamy, VV, κ.ά.
Έκδοση: (2020)

Surfactant Apoprotein D in Preterm Neonates with Acute Respiratory Distress Syndrome
ανά: S. A. Perepelitsa, κ.ά.
Έκδοση: (2009-10-01)

The Effects of Antenatal Corticosteroids and Surfactant Replacement on Neonatal Respiratory Distress Syndrome
ανά: Suada Heljić, κ.ά.
Έκδοση: (2009-08-01)

Surfactant and respiratory distress syndrome
ανά: A D Milner
Έκδοση: (1996-01-01)

Two Mutations in Surfactant Protein C Gene Associated with Neonatal Respiratory Distress
ανά: Anna Tarocco, κ.ά.
Έκδοση: (2015-01-01)

Exogenous surfactant transport through the pulmonary airways : improving surfactant replacement therapy for neonatal respiratory distress syndrome
ανά: Espinosa, Frank F. (Frank Francis)
Έκδοση: (2005)

Corrigendum to “Two Mutations in Surfactant Protein C Gene Associated with Neonatal Respiratory Distress”
ανά: Anna Tarocco, κ.ά.
Έκδοση: (2015-01-01)

Effects of Exogenous Surfactants on the Parameters of Blood Gas Composition in Neonatal Respiratory Distress Syndrome
ανά: S. A. Perepelitsa, κ.ά.
Έκδοση: (2007-06-01)

Replacement Therapy with the Surfactant Alveofact for Neonatal Respiratory Distress Syndrome: A Pilot Study
ανά: S. A. Perepelitsa
Έκδοση: (2014-08-01)

Management of respiratory distress syndrome in moderate/late preterm neonates: A Delphi consensus
ανά: Segundo Rite Gracia, κ.ά.
Έκδοση: (2024-11-01)

Outcomes Comparison of Early versus Late Surfactant Replacement Therapy in Neonates with Respiratory Distress Syndrome
ανά: Chutinun Wongkhonkaen, κ.ά.
Έκδοση: (2023-05-01)

Clinical efficacy of using pulmonary surfactant at different times in the treatment of neonatal respiratory distress syndrome
ανά: ZHU Ling, κ.ά.
Έκδοση: (2023-12-01)

An uncommon cause of neonatal respiratory distress
ανά: Gabriel Dimitriou, κ.ά.
Έκδοση: (2010-12-01)

Significance of surfactant proteins in respiratory distress syndrome in preterm infants
ανά: İ.A. Mirzayeva, κ.ά.
Έκδοση: (2024-04-01)

Exogenous surfactant therapy in non-respiratory distress syndrome
ανά: A Greenough
Έκδοση: (1996-01-01)

Surfactant BL-Induced Changes in Blood Gas Composition and Acid-Base Balance In Neonatal Respiratory Distress Syndrome
ανά: S. A. Perepelitsa, κ.ά.
Έκδοση: (2006-08-01)

Laryngeal Mask Airway Method for Minimally Invasive Surfactant Therapy in Neonates with Pneumothorax Complicating Respiratory Distress Syndrome
ανά: Joaquim M. B. Pinheiro, κ.ά.
Έκδοση: (2025-01-01)

Sedation for less invasive surfactant administration in preterm infants: a systematic review and meta-analysis
ανά: Moschino, L, κ.ά.
Έκδοση: (2022)

Surfactant as a drug carrier
ανά: Sett, A, κ.ά.
Έκδοση: (2023)

Comparison of the Consequences of Intratracheal Administration of Surfactant Plus Budesonide with Surfactant alone in Preterm Infants with Respiratory Distress Syndrome
ανά: Morteza Habibi, κ.ά.
Έκδοση: (2024-01-01)

Guidelines on the management of acute respiratory distress syndrome
ανά: Danny Francis McAuley, κ.ά.
Έκδοση: (2019-10-01)

The Outcomes of Preterm Infants with Neonatal Respiratory Distress Syndrome Treated by Minimally Invasive Surfactant Therapy and Non-Invasive Ventilation
ανά: Tzyy-Rong Huang, κ.ά.
Έκδοση: (2024-04-01)

Respiratory Distress and the Bacteria Causing Infection in the Neonates
ανά: Neihaya Heikmat Zaki
Έκδοση: (2012-06-01)

Early administration of the second surfactant dose in preterm infants with severe respiratory distress syndrome
ανά: Nilgün Köksal, κ.ά.
Έκδοση: (2009-12-01)

Management of neonates with respiratory distress syndrome in resource-limited settings
ανά: Radhika Singh, κ.ά.
Έκδοση: (2024-05-01)

INSURE method (INtubation-SURfactant-Extubation) in early and late premature neonates with respiratory distress: factors affecting the outcome and survival rate
ανά: Ali Naseh, κ.ά.
Έκδοση: (2014-06-01)

Construction and evaluation of neonatal respiratory failure risk prediction model for neonatal respiratory distress syndrome
ανά: Yupeng Lei, κ.ά.
Έκδοση: (2024-01-01)

Surfactant therapy in late preterm infants: respiratory distress syndrome and beyond
ανά: Ozge Sürmeli-Onay, κ.ά.
Έκδοση: (2012-06-01)

Exogenous Surfactant Therapy for Pediatric Patients with Acute Respiratory Distress Syndrome
ανά: James F Lewis, κ.ά.
Έκδοση: (1997-01-01)

Use of Surfactant-BL in Adult Patients with Acute Respiratory Distress Syndrome
ανά: A. V. Vlasenko, κ.ά.
Έκδοση: (2005-12-01)

Surfactant Protein D Is a Biomarker of Acute Respiratory Distress Syndrome
ανά: V. V. Moroz, κ.ά.
Έκδοση: (2013-08-01)

The association between sex and neonatal respiratory distress syndrome
ανά: Keren Fang, κ.ά.
Έκδοση: (2024-02-01)

Influence of catheter thickness on respiratory physiology during less invasive surfactant administration in extremely preterm infants
ανά: Chamindu C. Gunatilaka, κ.ά.
Έκδοση: (2024-09-01)

Pulmonary insufficiency of extreme prematurity (PIEP) and surfactant deficiency disease (SDD) – It is time to classify respiratory distress syndrome (RDS) in preterm neonates
ανά: Deepti Thandaveshwara, κ.ά.
Έκδοση: (2024-04-01)

Comparing the Effects of Two Surfactant Administration Methods: Minimally Invasive Surfactant Therapy (MIST) with Intubation (INSURE) in Infants with Respiratory Distress Syndrome
ανά: Hassan Boskabadi, κ.ά.
Έκδοση: (2024-10-01)